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Abstract
Objective—Atypical sequences of drug use progression are thought to have important
implications for the development of substance dependence. The extent to which this assumption
holds for South African populations is unknown. This paper attempts to address this gap by
examining the prevalence and correlates of atypical patterns of drug progression among South
Africans.
Method—Data on substance use and other mental health disorders from a nationally
representative sample of 4351 South Africans were analysed. Weighted cross tabulations were
used to estimate prevalence and correlates of atypical patterns of drug use progression.
Results—Overall, 12.2% of the sample reported atypical patterns of drug use progression. The
most common violation was the use of extra-medical drugs prior to alcohol and tobacco. Gender
was significantly associated with atypical patterns of drug use with the risk pattern varying by the
type of drug. None of the anxiety or mood disorders were associated with atypical patterns of use.
Atypical patterns of drug use were not associated with increased risk for a lifetime substance use
disorder.
Conclusion—Atypical patterns of drug use initiation seem more prevalent in South Africa
compared to other countries. The early use of extra-medical drugs is common, especially among
young women. Drug availability and social environmental factors may influence patterns of drug
use. The findings have important implications for prevention initiatives and future research.
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Introduction
Many studies have outlined a typical, staged pattern of progression into polysubstance use
(known as ‘the gateway effect’) whereby frequent and heavy alcohol and tobacco use
precedes and increases the risk of subsequent cannabis use, which in turn precedes the use of
other illicit drugs (such as cocaine and heroin).1-4 However the mechanisms underpinning
this gateway effect remain contentious, with ongoing debate focused on the meaning of the
predictive associations between the stages of drug use and the extent to which these
observed associations are causal.1,5-6 A range of studies have shown clearly that frequent
and regular use of alcohol, tobacco, and cannabis is associated with increased risk of
transition to other illicit drug use;1,2,4 especially among younger age cohorts.1,5 This
sequence of drug use progression has been observed for 85% to 90% of polysubstance users
in both developed1,2,5 and developing country settings.7-9
This pattern of drug use progression seems most characteristic of occasional drug users and
may not be typical of regular and problematic users of illicit drugs.10 Several studies of
problematic drug users and high-risk youth in the USA found that significant proportions of
participants violated this conventional sequence of drug use progression.6,11-14 These
studies reported that a quarter to more than half of participants initiated cannabis use prior to
using alcohol or tobacco and some started using other illicit drugs prior to using alcohol or
cannabis.11-14 Compared to individuals who followed the typical pattern of drug use
progression, violators of this pattern reported: earlier initiation into illicit drug use; greater
lifetime drug use;11,13-14 a higher prevalence of early onset internalizing mental disorders;15
were from different, typically younger, age cohorts;11-13,15-16 and came from more
disadvantaged backgrounds characterized by high drug availability and greater
poverty.6,11,13 While these findings suggest that violations from the gateway pattern may be
markers for progression to more serious drug-related problems, two recent studies using
representative samples found that deviations from the gateway pattern were relatively
uncommon (ranging from 3% to 5% of all drug users) and not predictive of later substance
dependence.15-16 Whether this is the case among South African drug using populations has
not been fully explored.
At present little is known about patterns and correlates of drug use progression among South
African samples. This lack of knowledge potentially hampers the development of
interventions that delay or halt drug use progression. This paper aims to redress this gap by
describing the prevalence and correlates of atypical patterns of drug use progression among
a representative sample of South African drug users.
Method
Data for the South Africa Stress and Health (SASH) study were collected between January
2002 and June 2004 from a national probability sample of 4351 adult South Africans.
Study sample
The sample was selected using a three-stage stratified and clustered area probability design
(see Williams et al., 2008 for a detailed account of the SASH study design).17 First, a
stratified sample of areas was selected from the 2001 South African census enumeration
areas (EAs). Then a probability sample of housing units was selected from each EA. Third,
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one adult respondent was randomly selected from the eligible persons in each sample
housing unit. Field interviews were conducted with 4433 (87.1%) of the selected
respondents. Due to quality concerns, only 4351 of these interviews (98.1%) were retained
for use in analysis.
Ethical approval for this study was granted by the University of Cape Town's Health
Research Committee.
Survey instrument
The World Health Organisation's Composite International Diagnostic Interview, Version 3.0
(CIDI 3.0) was used to assess the presence of DSM-IV (Diagnostic and Statistical Manual,
4th edition) disorders.18 The CIDI is a structured, lay-administered interview that generates
diagnoses according to the International Classification of Diseases, 10th edition (ICD-10)
and DSM-IV diagnostic systems.18-19 For this study, the English version of the CIDI was
translated into several other South African languages by panels of bilingual and multilingual
experts using iterative back-translation procedures.
Measures
Drug use—All respondents were asked whether they had ever used a) alcohol, b) tobacco,
c) cannabis, d) other drugs (including drugs such as cocaine, heroin, and methamphetamine
but excluding medicines), or e) extra-medical drugs (that is over-the-counter or prescription
medicines used to get ‘high’). Following a positive response to these questions, the CIDI
drug-use modules were administered to assess for the presence of lifetime and 12-month
substance use disorders (alcohol abuse, alcohol dependence, drug abuse, drug dependence)
and to obtain more information about drug-use patterns including age of onset, progression,
and problem severity.
Other mental disorders—Other mental disorders assessed in this study included: anxiety
disorders (panic disorder, agoraphobia, social phobia, generalised anxiety disorder, post-
traumatic stress disorder), mood disorders (major depressive disorder, dysthymia), and
impulse control disorders (intermittent explosive disorder). Lifetime prevalence, age of
onset, 12-month prevalence, and disorder severity for 12-month cases were assessed for
each disorder.
Covariates—This study included the following time-fixed covariates: sex, race/ethnicity
(black, white, coloured, Indian/Asian) and age (18-29 years, 30-39 years, 40-49 years, and
≥50 years). Time-varying covariates included residence (rural or urban), completed level of
education (none, grades 1-7, grades 8-11, Matric, and post-Matric levels), marital status
(married, previously married or not married), employment (employed or unemployed);
family income (zero, low average, high average, and high), and asset index. For the latter, 17
items that reflected individual and household wealth were used to construct a composite
asset score which was categorised into low, medium, and high asset classes.
Order of onset and gateway violations—The onset order for each drug used (alcohol,
tobacco, cannabis, other drugs and extra-medical drug use) was determined from
retrospective age-of-onset reports. We defined gateway violations as the following:
• the use of cannabis prior to both alcohol and tobacco use (cannabis gateway);
• other drug use prior to both alcohol and tobacco use (other drug use gateway);
• extra-medical drug use prior to both alcohol and tobacco use (extra-medical drug
use gateway).
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To account for the stratified multi-stage sample design, data were weighted to adjust for
differential probabilities of selection within households and for differential non-response. A
post-stratification weight was used to make the sample distribution comparable to the
distribution of the South African population in terms of age, sex, and province. The
weighting and geographic clustering of data were taken into account using the Taylor series
linearization method. Chi-square analyses were conducted to examine the bivariate
associations between socio-demographic variables and gateway violations among users of
each drug type. For these analyses, the reference group was the rest of the sample. Crude
associations between gateway violators and lifetime DSM-IV anxiety, mood, and substance
disorders were generated using other drug users as the reference group. For example, the
association between cannabis gateway violators and mental disorders was calculated with
the reference group being all participants who had ever used cannabis.
Results
Overall, 12.2% of respondents initiated substance use in an order that violated the typical
pattern of substance use progression (Table I). The most common violation was initiation of
extra-medical drug use before alcohol and tobacco (9.6%), followed by cannabis use before
the use of alcohol and tobacco (2.6%). Respondents in the ≥ 50 years age group were the
least likely to report illicit drug use before alcohol and tobacco, extra-medical drug use
before alcohol and tobacco, and any gateway violations compared to respondents in the
three younger age groups.
Among substance users, violations of the normative pattern of drug use initiation were much
more common among extra-medical drug users (53.2%) and illicit drug users (51.7%) than
cannabis users (36.0%). The violations were least common among alcohol (11.3%) and
tobacco users (10.8%) (Table II).
Table III presents the results of bivariate analyses examining socio-demographic correlates
of gateway violations. Gender was significantly associated with violations of each kind.
Female respondents were significantly less likely than males to have used cannabis prior to
using alcohol and tobacco and to have used other drugs prior to using alcohol and tobacco.
In contrast, compared to male respondents, female respondents had significantly greater
odds of initiating extra-medical drug use prior to alcohol and tobacco (Table III), with
women comprising almost two-thirds of this subset of gateway violators.
Although age was not significantly associated with the use of cannabis prior to the use of
alcohol and tobacco or the use of other drugs prior to alcohol and tobacco, respondents in
the younger age groups comprised the bulk of these gateway violators. Age was
significantly associated with the initiation of extra-medical drug use prior to the use of
alcohol and tobacco. More specifically, respondents between 18-29 years of age were
significantly more likely to use extra-medical drugs out of the gateway sequence compared
with respondents in the ≥ 50 years age category.
Race/Ethnicity was unrelated to gateway violations of any kind. Education level and
employment status were unrelated to the use of cannabis or extra-medical drugs before
alcohol and tobacco. However these variables were associated with the precocious use of
other drugs, with respondents with higher levels of education (Matric) and who were
employed, significantly more likely to report using other illicit drugs prior to alcohol and
tobacco than respondents who were unemployed and less educated (Grade 1-7). Finally,
residing in an urban area and having a medium asset score was significantly associated with
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using cannabis before alcohol and tobacco, but was not associated with the precocious use of
other illicit drugs or extra-medical drugs.
Table IV presents the results of bivariate analyses examining associations between mental
disorders and gateway violations. The presence of any lifetime disorder (including an
alcohol or drug-related diagnosis) was unrelated to the use of cannabis before alcohol and
tobacco, but significantly associated with the precocious use of both illicit and extra-medical
drugs (Table IV). Both of these gateway violations were associated with a decreased
likelihood of any type of lifetime mental disorder. When associations between specific types
of disorders and the three gateway violations were examined, we found that lifetime mood
and anxiety disorders were unrelated to gateway violations of any type. In contrast, the
presence of any type of substance use disorder was associated with a significantly reduced
likelihood of using illicit drugs prior to alcohol and tobacco or of using extra-medical drugs
before alcohol and tobacco. Specifically, atypical patterns of use among extra-medical drug
users were associated with significantly less chance of having a lifetime alcohol use
disorder.
Discussion
This study examined the order of onset of drug use and considered the possible impact of
deviations from the typical sequence of drug use initiation on the risk of developing a
substance use disorder using a representative sample of South African adults. To our
knowledge, this study is the first of its kind to describe violations of the gateway pattern of
drug use progression in Africa. More specifically, we examined three atypical sequence of
drug use progression: the use of cannabis prior to the use of alcohol and tobacco; other illicit
drug use prior to the use of alcohol and tobacco; and extra-medical drug use before alcohol
and tobacco.
In our study, 12.2% of respondents reported atypical sequences of drug use progression.
While this proportion is relatively small, it is more than double that reported in studies
conducted in developing country contexts where deviations from the normative pattern of
drug use typically ranged from 3% to 5% of the sample.15-16 In part, this could be due to the
fact that earlier studies did not consider extra-medical drug use prior to the use of alcohol
and tobacco as a violation of the gateway pattern of drug use progression. While our
examination of extra-medical drug use violators significantly increased the overall
proportion of respondents reporting an atypical sequence of drug use initiation (as extra-
medical drug use prior to the use of alcohol and tobacco was by far the most common
violation), the proportion of respondents reporting cannabis use prior to the use of alcohol
and tobacco was also slightly higher than the proportion presented in earlier studies.15-16
The proportion of substance users reporting violations of the gateway order of drug use
initiation was also much higher in this study compared to previous studies.15 Our study
found that more than half the extra-medical and illicit drug users and roughly a third of
cannabis users had atypical sequences of drug use progression. Taken together, these
findings suggest that the gateway pattern of drug use progression is not as common among
South African substance users as previously thought.
One reason for this may lie in the increased availability of cannabis and other illicit drugs in
South Africa since 1994.20 Among younger age cohorts, who form the bulk of the cannabis
and illicit drug gateway violators, this increased availability may have translated into
increased opportunities to use these substances. At the same time, tighter regulations around
the sale and use of alcohol and tobacco may have discouraged young people from starting
their drug use trajectories with these substances. This explanation is supported by findings
from studies conducted in other countries which report that opportunities to use substances
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and drug availability influence the order of drug use initiation and transitions to different
types of drugs.1,9
However, this explanation cannot fully account for the high proportion of respondents who
reported the use of extra-medical drugs before alcohol and tobacco. In this study, younger
age cohorts were most likely to report extra-medical drug use prior to the use of alcohol and
tobacco. Global epidemiological trends in substance use might help explain this finding,
with recent studies reporting significant increases in extra-medical drug use among young
people across a range of countries.21 Apart from these global trends, the precocious use of
these substances may also be driven by the fact that these substances are easy to obtain and
their use is relatively less stigmatised than the use of alcohol, tobacco, or illicit substances in
South Africa.22 The important role that stigma may play in choice of first drug is also
supported by our findings that female respondents were significantly more likely to report
using extra-medical drugs prior to alcohol and tobacco than their male counterparts and that
men were much more likely to report the early use of cannabis and other illicit drugs
compared to females. Compared to men, women's use of alcohol, tobacco and other
substances is still highly stigmatised in South Africa and is associated with a failure to fulfil
a socially acceptable female role and sexual availability.23 For women in this country, extra-
medical drugs may seem a socially acceptable alternative to alcohol and tobacco.
Finally, while other studies have suggested that deviations from the normative pattern of
drug use initiation are associated with the early onset of mood or anxiety disorders15, and
that many individuals who deviate from the gateway pattern also have co-occurring mental
health problems11-13, this study found no significant associations between atypical patterns
of drug use progression and the presence of mood or anxiety disorders. In addition, atypical
patterns of drug use did not increase the odds of developing a substance use disorder. This
challenges previous views that gateway violators have relatively more severe drug and
cooccurring mental health problems and are at greater risk for substance dependence.11-13
However, this finding should be interpreted with some caution. First, this survey did not
assess for a number of key DSM-IV disorders, such as impulse control disorders (with the
exception of intermittent explosive disorder) and psychotic disorders. Of particular concern
is the exclusion of the conduct disorders as these disorders are strongly associated with
increased risk for substance use, especially among adolescents.24 In addition, many of our
violators (particularly in the cannabis and extra-medical drug categories) were young and it
is quite possible that they had not yet progressed to abusive or dependent drug use or other
mental disorders. This may have skewed our findings regarding associations between
gateway violations and substance dependence.
Our findings on multiple patterns of drug use progression have important implications for
substance abuse prevention efforts in the country. Given large variations in the sequencing
of drug use, prevention efforts need to target common risk factors for the use of any
substance instead of only attempting to prevent the use of the so-called gateway substances
of alcohol, tobacco and cannabis. Second, substance abuse prevention initiatives that
traditionally have focused on the use of alcohol, tobacco and illicit drugs, also need to
address extra-medical drug use. Third, screening for the use of alcohol, tobacco and other
substances by mental health and other health care workers should also include questions on
the inappropriate and problematic use of medicines. Health care workers should also be
alerted to the high prevalence of extra-medical drug use among young women.
Despite these implications, findings from this study should be interpreted with reference to
several limitations. First, this cross-sectional data set relied on recall to assess age of onset
of substance use and patterns of drug use initiation. This may have led to reporting errors.
However, given limited differences between the various age cohorts in patterns of drug use
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initiation, it is unlikely that recall bias greatly influenced this study's findings. Second,
although the SASH study obtained a high response rate, reporting errors on the substance
use module of the CIDI may have occurred. It is possible that illicit drug use may have been
underreported, particularly as this is a stigmatised activity.24 Finally, our findings could
have been skewed by the exclusion of homeless and institutionalised people from the study.
Persons who find themselves homeless and institutionalised represent a particularly
vulnerable population group with typically more severe substance-related problems than the
general population.25
These limitations highlight the need for future research on patterns of drug use progression
in South Africa and their associated mental health consequences. To minimise concerns
regarding the accuracy of retrospective data, longitudinal prospective studies that track
young people over time and allow researchers to unpack patterns of drug use (and other
mental disorder problem) progression are required. Such studies would also benefit from
examining possible associations between other mental disorders not included in this study
(especially conduct disorders) and drug use progression. In addition, qualitative research that
provides detailed contextual information on factors associated with drug use progression
would be useful for guiding the development of interventions to delay or halt this
progression.
Conclusion
Despite some limitations, this is the first South African study to examine atypical sequences
of drug use progression. Key findings include: atypical patterns of drug use progression are
more common than in other settings and particularly prevalent among extra-medical and
illicit drug users; extra-medical gateway violators are mostly young and female; and
compared to non-violators, violators of the normative pattern of drug use progression are not
at greater risk for a mental disorder or a substance use disorder. These findings are
potentially valuable for guiding efforts to prevent or halt drug use progression across the
country. Most importantly, they suggest that common risk factors underpinning the initiation
of substance use, rather than particular drugs of abuse, should be the target of prevention
initiatives.
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